Castle Creek Pharmaceuticals Financing
Castle Creek Pharmaceuticals, Llc, Limited Liability Company just submitted form D because of $48.00 million equity financing. This is a new filing. Castle Creek Pharmaceuticals was able to fundraise $48.00 million. That is 100.00% of the financing offer. The total private offering amount was $48.00 million. The offering form was filed on 2016-10-14. The reason for the financing was: unspecified.
Castle Creek Pharmaceuticals is based in New Jersey. The company’s business is Pharmaceuticals. The form was signed by John F Pyne Attorney-in-Fact for Castle Creek Pharmaceuticals, LLC. The company was incorporated in 2015. The filler’s address is: 90 Washington Valley Road, Bedminster, Nj, New Jersey, 07921. Michael Derby is the related person in the form and it has address: C/O Castle Creek Pharmaceuticals, Llc, 90 Washington Valley Road, Bedminster, Nj, New Jersey, 07921. Link to Castle Creek Pharmaceuticals Filing: 000168748116000001.
Analysis of Castle Creek Pharmaceuticals Offering
On average, firms in the Pharmaceuticals sector, sell 60.90% of the total offering size. Castle Creek Pharmaceuticals sold 100.00% of the offering. Could this mean that the trust in Castle Creek Pharmaceuticals is high? The average fundraising size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 8,533.12% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this fundraising was set at $0. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Castle Creek Pharmaceuticals Also
The Form D signed by John F Pyne might help Castle Creek Pharmaceuticals, Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.